Darbufelone
CAS No. 139226-28-1
Darbufelone ( CI-1004 )
产品货号. M26144 CAS No. 139226-28-1
Darbufelone 是细胞 PGF2α 和 LTB4 产生的双重抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1077 | 有现货 |
|
| 10MG | ¥1806 | 有现货 |
|
| 25MG | ¥3969 | 有现货 |
|
| 50MG | ¥5792 | 有现货 |
|
| 100MG | ¥7995 | 有现货 |
|
| 500MG | ¥16038 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Darbufelone
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Darbufelone 是细胞 PGF2α 和 LTB4 产生的双重抑制剂。
-
产品描述Darbufelone is a dual inhibitor of cellular PGF2α and LTB4 production. Darbufelone potently inhibits PGHS-2 (IC50= 0.19 μM) but is much less potent with PGHS-1 (IC50=20 μM).(In Vitro):Darbufelone (5 - 60 μM) increases the cell growth inhibitory effects in A549, H520 and H460 cell lines with IC50s of 20, 21 and 15 μM.(In Vivo):Darbufelone (80 mg/kg/day) decreases the tumor volumes in a time-dependent manner. Darbufelone (20 or 40 mg/kg/day) dos not show any significant inhibition of tumor weight. At necropsy, Darbufelone (80 mg/kg/day) reduces the tumor weight by 30.2%.
-
体外实验Darbufelone is a noncompetitive inhibitor of PGHS-2 (Ki=10±5 μM). Darbufelone quenches the fluorescence of PGHS-2 at 325 nm (lambda(ex)=280 nm) with Kd=0.98±0.03 μM.To test the putative anti-proliferative effect of Darbufelone, A549, H520 and H460 cell lines are used, which are established from three distinct pathological subtypes of NSCLC (adenocarcinoma, squamous and large cell lung cancer respectively). Increasing concentrations of Darbufelone, ranging from 5 to 60 μM, are tested for 72 h. The cell growth inhibition of these three cell lines gradually increases with higher drug concentration. The IC50 of A549 and H520 are 20±3.6 and 21±1.8 μM, respectively, while the H460 has much lower IC50 (15±2.7 μM).
-
体内实验Darbufelone is a dual inhibitor of cellular PGF2R and LTB4 production. Darbufelone is orally active and nonulcerogenic in animal models of inflammation and arthritis. When mice are treated with Darbufelone at dosage of 80 mg/kg/day, the tumor volumes decrease in a time-dependent manner. In contrast, lower dose of Darbufelone (20 or 40 mg/kg/day) dos not show any significant inhibition of tumor weight. At necropsy, the tumor weight in mice treated with Darbufelone (80 mg/kg/day) is reduced by 30.2% in comparison with control group.
-
同义词CI-1004
-
通路GPCR/G Protein
-
靶点Prostaglandin Receptor
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number139226-28-1
-
分子量332.46
-
分子式C18H24N2O2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCC(C)(C)c1cc(\C=C2/SC(N)=NC2=O)cc(c1O)C(C)(C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
EP4 receptor antagon...
EP4受体拮抗剂1抑制人和小鼠EP4受体,IC50分别为6.1 nM和16.2 nM。
-
BGC201531
BGC201531 是一种 EP4 拮抗剂,用于治疗急性偏头痛。
-
Evatanepag
Evatanepag 是一种 EP2 受体选择性前列腺素 E2 (PGE2) 激动剂,可诱导局部骨形成,EC50 为 0.3 nM。
021-51111890
购物车()
sales@molnova.cn

